Figure 3.

Cumulative incidences of relapse/progression and overall survival probabilities. Cumulative incidence of relapse/progression after study inclusion (A) according to risk group and (B) for patients with primary refractory or unfavorable relapse. (C) From post-inclusion relapse/progression, overall survival (OS) of patients who underwent allogeneic stem-cell transplantation (alloSCT) or not. (D). From post-autologous stem-cell transplantation relapse, OS after matched analysis between patients who underwent alloSCT using a reduced-intensity conditioning regimen (RIC-allo) and patients who did not undergo alloSCT.